Related Experiment Video
Updated: Aug 4, 2025

Ultrasound Assessment of Endothelial-Dependent Flow-Mediated Vasodilation of the Brachial Artery in Clinical Research
Published on: October 22, 2014
The predictive value of interarm systolic blood pressure differences in patients with vascular disease: Sub-analysis
Mohammad Qadura1, Muzammil H Syed2, Sonia Anand3
1Department of Surgery, University of Toronto, Toronto, ON, M5S 1A1, Canada; Keenan Research Centre for Biomedical Science, Li Ka Shing Knowledge Institute of St. Michael's Hospital, Toronto, ON, M5B 1W8, Canada.
Insights
Systolic blood pressure interarm difference (IAD) does not predict cardiovascular events in patients with established vascular disease. However, the combination of rivaroxaban and aspirin significantly reduced major adverse cardiovascular events in these patients.
Area of Science:
- Cardiology
- Vascular Medicine
- Pharmacology
Background:
- Systolic blood pressure interarm difference (IAD) is a known predictor of cardiovascular events in primary prevention.
- Its predictive utility in patients with established cardiovascular disease requires further investigation.
Purpose of the Study:
- To evaluate the predictive value of IAD in patients with chronic coronary artery disease (CAD) or peripheral artery disease (PAD).
- To assess the efficacy of rivaroxaban plus aspirin versus aspirin alone in managing cardiovascular outcomes based on IAD.
Main Methods:
- Analysis of COMPASS trial data, comparing patients with IAD <15 mmHg and IAD ≥15 mmHg.
- Outcomes assessed included major adverse cardiovascular events (MACE) and major adverse limb events (MALE) over 30 months.
- Treatment effects of rivaroxaban plus aspirin versus aspirin alone were evaluated within IAD subgroups.
Main Results:
- Patients with IAD <15 mmHg showed similar incidence rates for MACE or MALE compared to those with IAD ≥15 mmHg, except for a higher stroke incidence.
- The combination of rivaroxaban and aspirin significantly reduced MACE or MALE in both IAD groups compared to aspirin alone.
- No significant interaction was observed between IAD status and treatment effect.
Conclusions:
- IAD measurement is not useful for risk stratification in patients with established vascular disease.
- Rivaroxaban plus aspirin demonstrates significant cardiovascular benefits irrespective of IAD in patients with established CAD or PAD.
Background And Aims:
Systolic blood pressure interarm difference (IAD) predicts cardiovascular morbidity and mortality in primary prevention populations. We examined the predictive value of IAD and the effects of treatment with the combination of rivaroxaban 2.5 mg twice daily plus aspirin 100 mg once daily versus aspirin 100 mg once daily according to IAD in patients with chronic coronary artery disease or peripheral artery disease.
Methods:
COMPASS trial patients with IAD <15 mmHg and IAD >15 mmHg were compared with respect to thirty-month incidence risk of: 1) composite of stroke, myocardial infarction, or cardiovascular death (MACE), 2) composite of acute limb-ischemia or vascular amputation (MALE), 3) composite of MACE or MALE, and 4) effects of treatment with the combination versus aspirin alone on these outcomes.
Results:
24,539 patients had IAD<15 mmHg and 2,776 had IAD ≥15 mmHg. Relative to patients with IAD ≥15 mm Hg, those with IAD<15 mmHg had similar incidence rates for all measured outcomes including the composite of MACE or MALE (HR 1.12 [95% CI: 0.95 to 1.31], p = 0.19), with the exception of stroke (HR 1.38 [95% CI: 1.02 to 1.88], p = 0.04). Compared to aspirin alone, the combination consistently reduced the composite of MACE or MALE in both IAD <15 mmHg (HR 0.74 [95% CI: 0.65-0.85], p < 0.0001, ARR = -23.1) and IAD>15 mmHg (HR 0.65 [95% CI: 0.44-0.96], p = 0.03; ARR = -32.6, p interaction = 0.53) groups.
Conclusions:
Unlike primary prevention populations, measuring IAD for risk stratification purposes does not appear to be useful in patients with established vascular disease.
Related Concept Videos
Pre-Procedural Guidelines for Assessing Blood Pressure
Special considerations while measuring blood pressure
Monitoring Both Arms:
Monitoring BP in both arms during the initial assessment is advisable, as the systolic value may differ by five to ten mm Hg between arms. For subsequent BP assessments, use the arm with the higher reading.
Sites for measruring blood pressure
The Brachial Artery: Primary Site for Blood Pressure Measurement
Assessment of blood pressure in brachial artery(two-step method)
Assessment of blood pressure in brachial artery(one-step method)
Prepare for the Procedure:
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

